Dr. Lal PathLabs LimitedNSE: LALPATHLAB

Press Release Aug 07 2024

· Issued by Dr. Lal PathLabs Limited

Filed with NSE · · 3 pages · English

Summary by 6ix AI

The report highlights a revenue increase compared to the same quarter last year, along with significant growth in EBITDA and profit after tax. Additionally, the company has declared an interim dividend for the current fiscal year.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated August 07, 2024, titled "Press Release on Un-audited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2024".

Dr. Lal PathLabs Limited on 6ix

Earlier from Dr. Lal PathLabs

Later from Dr. Lal PathLabs

All Dr. Lal PathLabs news releases